Search alternatives:
nn decrease » _ decrease (Expand Search), mean decrease (Expand Search), gy decreased (Expand Search)
ns decrease » _ decrease (Expand Search), use decreased (Expand Search), ash decreased (Expand Search)
we decrease » _ decrease (Expand Search), mean decrease (Expand Search), teer decrease (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
Showing 67,581 - 67,600 results of 103,360 for search '(( 5 ((a decrease) OR (nn decrease)) ) OR ( 50 ((ns decrease) OR (we decrease)) ))', query time: 1.47s Refine Results
  1. 67581
    Dirt on photovoltaic modules and efficient energy generation in the Brazilian semiarid

    Dirt on photovoltaic modules and efficient energy generation in the Brazilian semiarid by Tiago L. S. de Souza (12820142)

    Published 2022
    Save to List
    Saved in:
  2. 67582
    BIOCHEMICAL AND PIGMENT ANALYSIS ON PHYCOREMEDIATED MICROALGAL BIOMASS

    BIOCHEMICAL AND PIGMENT ANALYSIS ON PHYCOREMEDIATED MICROALGAL BIOMASS by G. k. Saravanan (515483)

    Published 2014
    Save to List
    Saved in:
  3. 67583
    Temperature influence on mobility and charge density model of photovoltaic cells

    Temperature influence on mobility and charge density model of photovoltaic cells by J.S.T. Souza (6380096)

    Published 2019
    Save to List
    Saved in:
  4. 67584
    Supplementary Material for: Cerebral Hemodynamic Failure Presenting as Limb-Shaking Transient Ischemic Attacks

    Supplementary Material for: Cerebral Hemodynamic Failure Presenting as Limb-Shaking Transient Ischemic Attacks by Nedelmann M. (4127125)

    Published 2011
    Save to List
    Saved in:
  5. 67585
    Unexpected transient phenomena in positive lightning

    Unexpected transient phenomena in positive lightning by Ziqin Ding (8470035)

    Published 2022
    Save to List
    Saved in:
  6. 67586
    <i>apol1</i> morphant zebrafish embryos display generalized edema and glomerular filtration defects indicative of nephropathy.

    <i>apol1</i> morphant zebrafish embryos display generalized edema and glomerular filtration defects indicative of nephropathy. by Blair R. Anderson (765261)

    Published 2015
    “…<p>Representative live images of (A) sham-injected control larvae, and (B) <i>apol1</i> morpholino (MO) injected larvae at 5 dpf. …”
    Save to List
    Saved in:
  7. 67587
    Rhinorrhea-free days up to day 10.

    Rhinorrhea-free days up to day 10. by Bruno Martins Tomazini (6509528)

    Published 2024
    “…<div><p>Background</p><p>Halofuginone (PJS-539) is an oral prolyl-tRNA synthetase inhibitor that has a potent <i>in vitro</i> activity against SARS-CoV-2 virus. …”
    Save to List
    Saved in:
  8. 67588
    Vomit-free days up to day 10.

    Vomit-free days up to day 10. by Bruno Martins Tomazini (6509528)

    Published 2024
    “…<div><p>Background</p><p>Halofuginone (PJS-539) is an oral prolyl-tRNA synthetase inhibitor that has a potent <i>in vitro</i> activity against SARS-CoV-2 virus. …”
    Save to List
    Saved in:
  9. 67589
    Table_1_Impact of the COVID-19 Lockdown on Air Quality and Resulting Public Health Benefits in the Mexico City Metropolitan Area.DOCX

    Table_1_Impact of the COVID-19 Lockdown on Air Quality and Resulting Public Health Benefits in the Mexico City Metropolitan Area.DOCX by Iván Y. Hernández-Paniagua (10430552)

    Published 2021
    “…SO<sub>2</sub> decreased only during Phase 3 in a near-road environment. …”
    Save to List
    Saved in:
  10. 67590
    Symptoms free-days up to day 10.

    Symptoms free-days up to day 10. by Bruno Martins Tomazini (6509528)

    Published 2024
    “…<div><p>Background</p><p>Halofuginone (PJS-539) is an oral prolyl-tRNA synthetase inhibitor that has a potent <i>in vitro</i> activity against SARS-CoV-2 virus. …”
    Save to List
    Saved in:
  11. 67591
    Respiratory symptoms-free days up to day 10.

    Respiratory symptoms-free days up to day 10. by Bruno Martins Tomazini (6509528)

    Published 2024
    “…<div><p>Background</p><p>Halofuginone (PJS-539) is an oral prolyl-tRNA synthetase inhibitor that has a potent <i>in vitro</i> activity against SARS-CoV-2 virus. …”
    Save to List
    Saved in:
  12. 67592
    Other symptoms-free days up to day 10.

    Other symptoms-free days up to day 10. by Bruno Martins Tomazini (6509528)

    Published 2024
    “…<div><p>Background</p><p>Halofuginone (PJS-539) is an oral prolyl-tRNA synthetase inhibitor that has a potent <i>in vitro</i> activity against SARS-CoV-2 virus. …”
    Save to List
    Saved in:
  13. 67593
    Diarrhea-free days up to day 10.

    Diarrhea-free days up to day 10. by Bruno Martins Tomazini (6509528)

    Published 2024
    “…<div><p>Background</p><p>Halofuginone (PJS-539) is an oral prolyl-tRNA synthetase inhibitor that has a potent <i>in vitro</i> activity against SARS-CoV-2 virus. …”
    Save to List
    Saved in:
  14. 67594
    Gastrointestinal symptoms-free days up to day 10.

    Gastrointestinal symptoms-free days up to day 10. by Bruno Martins Tomazini (6509528)

    Published 2024
    “…<div><p>Background</p><p>Halofuginone (PJS-539) is an oral prolyl-tRNA synthetase inhibitor that has a potent <i>in vitro</i> activity against SARS-CoV-2 virus. …”
    Save to List
    Saved in:
  15. 67595
    Nausea-free days up to day 10.

    Nausea-free days up to day 10. by Bruno Martins Tomazini (6509528)

    Published 2024
    “…<div><p>Background</p><p>Halofuginone (PJS-539) is an oral prolyl-tRNA synthetase inhibitor that has a potent <i>in vitro</i> activity against SARS-CoV-2 virus. …”
    Save to List
    Saved in:
  16. 67596
    Flow of patients in Halos trial.

    Flow of patients in Halos trial. by Bruno Martins Tomazini (6509528)

    Published 2024
    “…<div><p>Background</p><p>Halofuginone (PJS-539) is an oral prolyl-tRNA synthetase inhibitor that has a potent <i>in vitro</i> activity against SARS-CoV-2 virus. …”
    Save to List
    Saved in:
  17. 67597
    Cough-free days up to day 10.

    Cough-free days up to day 10. by Bruno Martins Tomazini (6509528)

    Published 2024
    “…<div><p>Background</p><p>Halofuginone (PJS-539) is an oral prolyl-tRNA synthetase inhibitor that has a potent <i>in vitro</i> activity against SARS-CoV-2 virus. …”
    Save to List
    Saved in:
  18. 67598
    Dyspnea-free days up to day 10.

    Dyspnea-free days up to day 10. by Bruno Martins Tomazini (6509528)

    Published 2024
    “…<div><p>Background</p><p>Halofuginone (PJS-539) is an oral prolyl-tRNA synthetase inhibitor that has a potent <i>in vitro</i> activity against SARS-CoV-2 virus. …”
    Save to List
    Saved in:
  19. 67599
    Image_1_Maternal Tn Immunization Attenuates Hyperoxia-Induced Lung Injury in Neonatal Rats Through Suppression of Oxidative Stress and Inflammation.TIF

    Image_1_Maternal Tn Immunization Attenuates Hyperoxia-Induced Lung Injury in Neonatal Rats Through Suppression of Oxidative Stress and Inflammation.TIF by Chung-Ming Chen (2155318)

    Published 2019
    “…Female Sprague–Dawley rats (6 weeks old) were intraperitoneally immunized five times with Tn (50 μg/dose) or carrier protein at biweekly intervals on 8, 6, 4, 2, and 0 weeks before the day of delivery. …”
    Save to List
    Saved in:
  20. 67600
    Deep White Matter in Huntington's Disease

    Deep White Matter in Huntington's Disease by Owen Phillips (453524)

    Published 2014
    “…We collected Pre-HD subjects (n = 25), HD patients (n = 25) and healthy control subjects (n = 50). …”
    Save to List
    Saved in:

Search Tools: